Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (<scp>MCL</scp>) ‐ outcomes and mutation profile from venetoclax resistant <scp>MCL</scp> patientsShuangtao Zhao, Preetesh Jain, Shaojun Zhang et al.|American Journal of Hematology|2020Cited by 84
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell LymphomaPreetesh Jain, Michael Wang, Shuangtao Zhao et al.|Journal of Clinical Oncology|2021Cited by 82